October 4, 2023 — A new artificial intelligence (AI) model combines imaging information with clinical patient data to improve diagnostic performance on chest X-rays, according to a study published in Radiology, a journal of the Radiological Society of North America (
October 4, 2023 — An AI chest X-ray foundation model for disease detection demonstrated racial and sex-related bias leading to uneven performance across patient subgroups and may be unsafe for clinical applications, according to a study published today in
October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of P-Cure’s proton therapy system through integration with RaySearch’s systems RayStation and RayCare.
October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct.
October 2, 2023 — Digital radiography company Swissray has announced a strategic partnership with Koning Corporation, provider of advanced breast imaging solutions, whereby Swissray becomes the authorized distributor of the Koning Vera Breast CT for the Florida and Arizona regions.
October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests.
October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation, a large new international study suggests.
